Enfermedad renal crónica (ERC) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, requiring dialysis or a kidney transplant. Terapia con células madre has emerged as a potential treatment option for late-stage CKD, ofreciendo esperanza a los pacientes con esta condición debilitante.
Late-Stage Chronic Kidney Disease: Una descripción general
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. This can cause a range of symptoms, incluyendo la fatiga, nausea, hinchazón, and difficulty concentrating. A medida que avanza la enfermedad, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Terapia con células madre: A Potential Treatment Option
Las células madre son células no especializadas que tienen la capacidad de diferenciarse en varios tipos de células., incluyendo células renales. Researchers believe that terapia con células madre could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
